APSR2026-846

 
Late-Breaking
Submitted
Oral Presentation
AO30-004
 
 
https://storage.unitedwebnetwork.com/files/1285/1221218-46903-APSR2026-AO30-0004_440977.pptx
Format: PPTX Only
 
Format: PDF Only
16. Interstitial Lung Disease
5

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Farhana Ibrahim Syuaib * Faculty of Medicine, Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Arini Purwono - Faculty of Medicine, Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Fanny Fachrucha - Faculty of Medicine, Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Fariz Nurwidya - Faculty of Medicine, Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Sita Andarini - Faculty of Medicine, Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Farhana Ibrahim
Syuaib
farhana.ibrahim@ui.ac.id
+6281231747092
Under 30
Indonesia
Original Research
Clinical Factors Associated with Pulmonary Hypertension in CTD-ILD: Insights from a Tertiary Hospital in Indonesia
Maximum 25 words
Abstract Content
Pulmonary hypertension (PH) is a common complication of connective tissue disease–associated interstitial lung disease (CTD-ILD), with a prevalence estimated at 7%–24% (Motschwiller C et al, Breath (Sheff), 2025, 21, 1-11). Parenchymal fibrosis leads to capillary bed destruction and chronic hypoxia, promoting vasoconstriction and vascular remodeling that increase pulmonary vascular resistance ( Nathan et al, Am J Respir Crit Care Med, 2007, 175, 875-880). The development of PH increased morbidity and mortality, yet early recognition of patients at risk remains challenging (Motschwiller C et al, Breath (Sheff), 2025, 21, 1-11). This study aims to identify clinical factors associated with pulmonary hypertension in CTD-ILD at a tertiary hospital in Indonesia.
This is a cross-sectional study conducted at Persahabatan National Respiratory Referral Hospital from January 2023 to March 2024. Patients from the ILD registry with confirmed CTD-ILD diagnosis who underwent echocardiographic evaluation were included. Demographic characteristics, nutritional status, HRCT patterns, lung function, and immune serology results were collected. Pulmonary hypertension probability was determined by transthoracic echocardiography by a cardiologist. Bivariate analyses were conducted using Fisher’s exact test and Mann–Whitney U test.
A total of 20 CTD-ILD patients were included, with a mean age of 55.9 ± 12.9 years and 80% were female. The mean body mass index (BMI) was 23.0 ± 8.0 kg/m², with overweight and obesity (30%). CTD-ILD subtypes include SSc (n=7), RA (n=3), and SLE (n=1), with the remaining classified as uncharacterized autoimmune disease. Fibrotic HRCT patterns were identified in 13 patients with fibrotic NSIP and UIP pattern as dominant findings. Lung function test showed restriction (n=14), obstruction (n=3), and diffusion impairment (n=14). A high probability of pulmonary hypertension was observed in 8 patients. Pulmonary hypertension was significantly associated with BMI (p = 0.014) but not with age, gender, restriction, or fibrotic HRCT pattern (p>0.005).
This study identified nutritional status as a factor associated with pulmonary hypertension in CTD-ILD. Other clinical and radiologic features showed no significant association. Further studies are needed to validate these findings.
 
 
 
 
 
Yes
No
 
JPG or JPEG or PNG format ONLY
CTD-ILD, ILD, interstitial lung disease, pulmonary hypertension
maximum 3 keywords and no abbreviations, separated by commas
-
338